Institutul Clinic Fundeni, Centrul de Hematologie si Transplant Medular Stefan Berceanu
About Institutul Clinic Fundeni, Centrul de Hematologie si Transplant Medular Stefan Berceanu
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Institutul Clinic Fundeni, Centrul de Hematologie si Transplant Medular Stefan Berceanu
During the past decade, Institutul Clinic Fundeni, Centrul de Hematologie si Transplant Medular Stefan Berceanu conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Phase III Randomized Study of Amonafide (AS1413) and Cytarabine Versus Daunorubicin and Cytarabine in Patients With Secondary Acute Myeloid Leukemia (AML)- the ACCEDE Study
2007-06-01
Unknown status
420
A Phase 3 Study of Brentuximab Vedotin (SGN-35) in Patients at High Risk of Residual Hodgkin Lymphoma Following Stem Cell Transplant (The AETHERA Trial)
2010-04-30
2020-04-27
Completed
329
Study of Elacytarabine Versus Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia (AML)
2010-06-01
2013-06-01
Completed
381
A Treatment-Option Protocol to Provide Brentuximab Vedotin to Eligible Patients Completing Studies SGN35-005 or C25001
No longer available
Comparison of Pixantrone + Rituximab With Gemcitabine + Rituximab in Patients With Aggressive B-cell Non-Hodgkin Lymphoma or Follicular Grade 3 Lymphoma Who Have Relapsed After Therapy and Are Not Eligible for Stem Cell Transplant
2011-04-20
2018-09-14
Completed
312
ECHELON-2: A Comparison of Brentuximab Vedotin and CHP With Standard-of-care CHOP in the Treatment of Patients With CD30-positive Mature T-cell Lymphomas
2013-01-31
2020-10-02
Completed
452
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Institutul Clinic Fundeni, Centrul de Hematologie si Transplant Medular Stefan Berceanu"
#1 collaborator was "Millennium Pharmaceuticals, Inc." with 3 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Institutul Clinic Fundeni, Centrul de Hematologie si Transplant Medular Stefan Berceanu
According to Clinical.Site data, the most researched conditions in "Institutul Clinic Fundeni, Centrul de Hematologie si Transplant Medular Stefan Berceanu" are
"Disease, Hodgkin" (2 trials), "Acute Myeloid Leukemia (AML)" (1 trials), "Anaplastic Large-Cell Lymphoma" (1 trials), "DLBCL Transformed From Indolent Lymphoma" (1 trials) and "Diffuse Large B-cell Lymphoma" (1 trials). Many other conditions were trialed in "Institutul Clinic Fundeni, Centrul de Hematologie si Transplant Medular Stefan Berceanu" in a lesser frequency.
Clinical Trials Intervention Types at Institutul Clinic Fundeni, Centrul de Hematologie si Transplant Medular Stefan Berceanu
Most popular intervention types in "Institutul Clinic Fundeni, Centrul de Hematologie si Transplant Medular Stefan Berceanu" are "Drug" (6 trials). Other intervention types were less common.
The name of intervention was led by "brentuximab vedotin" (3 trials), "Amonafide and Cytarabine" (1 trials), "Daunorubicin and Cytarabine" (1 trials), "Elacytarabine" (1 trials) and "Gemcitabine + Rituximab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Institutul Clinic Fundeni, Centrul de Hematologie si Transplant Medular Stefan Berceanu
The vast majority of trials in "Institutul Clinic Fundeni, Centrul de Hematologie si Transplant Medular Stefan Berceanu" are
6 trials for "All" genders.
Clinical Trials Status at Institutul Clinic Fundeni, Centrul de Hematologie si Transplant Medular Stefan Berceanu
Currently, there are NaN active trials in "Institutul Clinic Fundeni, Centrul de Hematologie si Transplant Medular Stefan Berceanu".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Institutul Clinic Fundeni, Centrul de Hematologie si Transplant Medular Stefan Berceanu,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Institutul Clinic Fundeni, Centrul de Hematologie si Transplant Medular Stefan Berceanu, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".